Products for Research Use Only
RegisterLogin

PD184161

CAT: 0804-HY-10174-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-10174-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
PD184161 is an orally active MEK inhibitor. PD184161 inhibits MEK activity (IC50=10-100 nM) in a time- and concentration-dependent manner. PD184161 inhibits cell proliferation and induces apoptosis. PD184161 produces depressive-like behavior[1][2].
CAS Number
212631-67-9
UNSPSC
12352005
Hazard Statement
H315, H319
Target
Apoptosis; MEK
Type
Reference compound
Related Pathways
Apoptosis; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/pd184161.html
Purity
98.08
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NOCC1CC1)C2=CC(Br)=C(F)C(F)=C2NC(C(Cl)=C3)=CC=C3I
Molecular Formula
C17H13BrClF2IN2O2
Molecular Weight
557.56
Precautions
H315, H319
References & Citations
[1]Klein PJ, et al. The effects of a novel MEK inhibitor PD184161 on MEK-ERK signaling and growth in human liver cancer. Neoplasia. 2006 Jan;8 (1) :1-8.|[2]Gladbach A, et al. ERK inhibition with PD184161 mitigates brain damage in a mouse model of stroke. J Neural Transm (Vienna) . 2014 May;121 (5) :543-7.|[3]Duman CH, et al. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol Psychiatry. 2007 Mar 1;61 (5) :661-70.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
MEK

Alternative Products

CatalogName
BUP12122-01PD184161
A22601-200PD184161 200mg
A22601-500PD184161 500mg
A22601-25PD184161 25mg
A22601-5PD184161 5mg
A22601-100PD184161 100mg
A22601-50PD184161 50mg
A22601-10PD184161 10mg
A22601-2PD184161 2mg
A22601-1PD184161 1mg

Popular Products